tiprankstipranks
Trending News
More News >
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market

Assertio Therapeutics (ASRT) Income Statement

Compare
1,157 Followers

Assertio Therapeutics Income Statement

Last quarter (Q3 2025), Assertio Therapeutics's total revenue was $49.46M, an increase of 69.36% from the same quarter last year. In Q3, Assertio Therapeutics's net income was $11.45M. See Assertio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 124.96M$ 152.07M$ 156.23M$ 111.01M$ 108.08M
Gross Profit
$ 85.73M$ 125.05M$ 137.49M$ 95.18M$ 92.30M
Operating Expenses
$ 110.21M$ 368.58M$ 98.08M$ 85.76M$ 174.46M
Depreciation and Amortization
$ 25.83M$ 28.23M$ 33.40M$ 29.11M$ 26.43M
EBITDA
$ 5.15M$ 53.17M$ 90.17M$ 38.78M$ -16.28M
Operating Income
$ -24.48M$ -243.54M$ 39.41M$ 9.42M$ -82.16M
Other Income/Expenses
$ 2.95M$ -10.52M$ -8.24M$ -9.98M$ 71.38M
Pretax Income
$ -21.53M$ -254.05M$ 31.17M$ -553.00K$ -10.78M
Net Income
$ -21.58M$ -331.94M$ 109.63M$ -1.28M$ -28.14M
Per Share Metrics
Basic EPS
$ -3.45$ -70.05$ 34.95$ -0.45$ -16.05
Diluted EPS
$ -3.45$ -70.05$ 30.45$ -0.45$ -16.05
Weighted Average Shares Outstanding
6.35M 4.74M 3.13M 2.88M 1.75M
Weighted Average Shares Outstanding (Diluted)
6.35M 4.74M 3.64M 2.88M 1.75M
Currency in USD

Assertio Therapeutics Earnings and Revenue History